| Product Code: ETC4633236 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Non-Oncology Precision Medicine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Israel Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Israel Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Israel Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine approaches in healthcare |
4.2.2 Technological advancements in genomics and molecular diagnostics |
4.2.3 Growing focus on improving patient outcomes and reducing healthcare costs |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine technologies and treatments |
4.3.2 Limited reimbursement policies for precision medicine services |
4.3.3 Regulatory challenges and data privacy concerns |
5 Israel Non-Oncology Precision Medicine Market Trends |
6 Israel Non-Oncology Precision Medicine Market Segmentations |
6.1 Israel Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2021-2031F |
6.1.3 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.4 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2021-2031F |
6.1.5 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2021-2031F |
6.1.6 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2021-2031F |
6.2.3 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2021-2031F |
6.2.4 Israel Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2021-2031F |
7 Israel Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Israel Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Israel Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Israel Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering non-oncology precision medicine services |
8.2 Percentage of healthcare professionals trained in precision medicine practices |
8.3 Rate of successful treatment outcomes using precision medicine methodologies |
9 Israel Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Israel Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Israel Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Israel Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 Israel Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here